Skip to main content Accessibility help
×
×
Home

Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program

  • Archana Asundi (a1), Maggie Stanislawski (a2) (a3) (a4), Payal Mehta (a5), Anna E. Baron (a3), Hillary J. Mull (a6), P. Michael Ho (a2) (a4) (a7), Peter J. Zimetbaum (a8) (a9), Kalpana Gupta (a5) (a6) (a10) and Westyn Branch-Elliman (a5) (a6) (a9)...

Abstract

Objective:

To measure the association between receipt of specific infection prevention interventions and procedure-related cardiac implantable electronic device (CIED) infections.

Design:

Retrospective cohort with manually reviewed infection status.

Setting:

Setting: National, multicenter Veterans Health Administration (VA) cohort.

Participants:

Sampling of procedures entered into the VA Clinical Assessment Reporting and Tracking-Electrophysiology (CART-EP) database from fiscal years 2008 through 2015.

Methods:

A sample of procedures entered into the CART-EP database underwent manual review for occurrence of CIED infection and other clinical/procedural variables. The primary outcome was 6-month incidence of CIED infection. Measures of association were calculated using multivariable generalized estimating equations logistic regression.

Results:

We identified 101 procedure-related CIED infections among 2,098 procedures (4.8% of reviewed sample). Factors associated with increased odds of infections included (1) wound complications (adjusted odds ratio [aOR], 8.74; 95% confidence interval [CI], 3.16–24.20), (2) revisions including generator changes (aOR, 2.4; 95% CI, 1.59–3.63), (3) an elevated international normalized ratio (INR) >1.5 (aOR, 1.56; 95% CI, 1.12–2.18), and (4) methicillin-resistant Staphylococcus colonization (aOR, 9.56; 95% CI, 1.55–27.77). Clinically effective prevention interventions included preprocedural skin cleaning with chlorhexidine versus other topical agents (aOR, 0.41; 95% CI, 0.22–0.76) and receipt of β-lactam antimicrobial prophylaxis versus vancomycin (aOR, 0.60; 95% CI, 0.37–0.96). The use of mesh pockets and continuation of antimicrobial prophylaxis after skin closure were not associated with reduced infection risk.

Conclusions:

These findings regarding the real-world clinical effectiveness of different prevention strategies can be applied to the development of evidence-based protocols and infection prevention guidelines specific to the electrophysiology laboratory.

Copyright

Corresponding author

Author for correspondence: Westyn Branch-Elliman, Email: wbranche@bidmc.harvard.edu

Footnotes

Hide All

PREVIOUS PRESENTATION: This work was presented as a poster abstract (no. 2126) at IDWeek 2018, on October 6, 2018, in San Francisco, California.

Footnotes

References

Hide All
1.Greenspon, AJ, Patel, JD, Lau, E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States, 1993–2008. J Am Coll Cardiol 2011;58:10011006.
2.Greenspon, AJ, Patel, JD, Lau, E, et al. Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. J Am Coll Cardiol 2012;60:15401545.
3.Mehrotra, P, Gupta, K, Strymish, J, et al. Implementation of infection prevention and antimicrobial stewardship in cardiac electrophysiology laboratories: results from the SHEA Research Network. Infect Control Hosp Epidemiol 2017;38:496498.
4.de Oliveira, JC, Martinelli, M, Nishioka, SA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol 2009;2:2934.
5.Strymish, J, Welch, B, Peralta, A, et al. Implementation of a surgical site infection prevention bundle in the cardiac electrophysiology laboratory for management of a cluster of device infections. Open Forum Infect Dis 2016;3:S1.
6.Ali, S, Kanjwal, Y, Bruhl, SR, et al. A meta-analysis of antibacterial envelope use in prevention of cardiovascular implantable electronic device infection. Therapeut Adv Infect Dis 2017;4:7582.
7.Ahsan, SY, Saberwal, B, Lambiase, PD, et al. A simple infection-control protocol to reduce serious cardiac device infections. Europace 2014;16:14821489.
8.Manolis, AS, Melita, H. Prevention of cardiac implantable electronic device infections: single operator technique with use of povidone-iodine, double gloving, meticulous aseptic/antiseptic measures and antibiotic prophylaxis. Pacing Clin Electrophysiol 2017;40:2634.
9.Krahn, AD, Longtin, Y, Philippon, F, et al. Prevention of arrhythmia device infection trial: the PADIT trial. J Am Coll Cardiol 2018;72:30983109.
10.Polyzos, KA, Konstantelias, AA, Falagas, ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace 2015;17:767777.
11.Nichols, CI, Vose, JG. Incidence of bleeding-related complications during primary implantation and replacement of cardiac implantable electronic devices. J Am Heart Assoc 2017;6:pii: e004263.
12.Branch-Elliman, W, Stanislawski, M, Strymish, J, et al. Cardiac electrophysiology laboratories: a potential target for antimicrobial stewardship and quality improvement? Infect Control Hosp Epidemiol 2016;37:10051011.
13.Baddour, LM, Epstein, AE, Erickson, CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 2010;121:458477.
14.Sandoe, JA, Barlow, G, Chambers, JB, et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother 2015;70:325359.
15.Nielsen, JC, Gerdes, JC, Varma, N. Infected cardiac-implantable electronic devices: prevention, diagnosis, and treatment. Eur Heart J 2015;36:24842490.
16.Epitools: Epidemiology Tools. R package version 0.5-92017 [computer program].
17.Elixhauser, A, Steiner, C, Harris, DR, Coffey, RM. Comorbidity measures for use with administrative data. Med Care 1998;36:827.
18.R: A Language and Environment for Statistical Computing [computer program]. Vienna, Austria: R Foundation for Statistical Computing; 2017.
19.Asundi, A, Stanislawski, M, Mehta, P, et al. Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program. Infect Control Hosp Epidemiol 2018;39:10301036.
20.Chen, HC, Chen, MC, Chen, YL, et al. Bundled preparation of skin antisepsis decreases the risk of cardiac implantable electronic device-related infection. Europace 2016;18:858867.
21.George, S, Leasure, AR, Horstmanshof, D. Effectiveness of decolonization with chlorhexidine and mupirocin in reducing surgical site infections: a systematic review. Dimen Crit Care Nurs 2016;35:204222.
22.Lee, WH, Huang, TC, Lin, LJ, et al. Efficacy of postoperative prophylactic antibiotics in reducing permanent pacemaker infections. Clin Cardiol 2017;40:559565.
23.Basil, A, Lubitz, SA, Noseworthy, PA, et al. Periprocedural antibiotic prophylaxis for cardiac implantable electrical device procedures: results from a Heart Rhythm Society survey. JACC Clin Electrophysiol 2017;3:632634.
24.Bratzler, DW. Surgical care improvement project performance measures: good but not perfect. Clin Infect Dis 2013;56:428429.
25.Harbarth, S, Samore, MH, Lichtenberg, D, Carmeli, Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000;101:29162921.
26.Rosenberger, LH, Politano, AD, Sawyer, RG. The surgical care improvement project and prevention of post-operative infection, including surgical site infection. Surg Infect (Larchmt) 2011;12:163168.
27.Bratzler, DW, Houck, PM, Richards, C, et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg 2005;140:174182.
28.Bratzler, DW, Dellinger, EP, Olsen, KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013;70:195283.
29.Bolon, MK, Morlote, M, Weber, SG, et al. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis 2004;38:13571363.
30.Kang, FG, Liu, PJ, Liang, LY, et al. Effect of pocket irrigation with antimicrobial on prevention of pacemaker pocket infection: a meta-analysis. BMC Cardiovasc Disord 2017;17:256.
31.Lakshmanadoss, U, Nuanez, B, Kutinsky, I, et al. Incidence of pocket infection postcardiac device implantation using antibiotic versus saline solution for pocket irrigation. Pacing Clin Electrophysiol 2016;39:978984.
32.Edin, ML, Miclau, T, Lester, GE, Lindsey, RW, Dahners, LE. Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthop Relat Res 1996:245251.
33.Henrikson, CA, Sohail, MR, Acosta, H, et al. Antibacterial envelope is associated with low infection rates after implantable cardioverter-defibrillator and cardiac resynchronization therapy device replacement: results of the citadel and centurion studies. JACC Clin Electrophysiol 2017;3:11581167.
34.Koerber, SM, Turagam, MK, Winterfield, J, Gautam, S, Gold, MR. Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: a meta-analysis. J Cardio Electrophysiol 2018;29:609615.
35.Tarakji, KG, Mittal, S, Kennergren, C, et al. Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med 2019. doi: 10.1056/NEJMoa1901111. [Epub ahead of print].
36.Turagam, MK, Nagarajan, DV, Bartus, K, Makkar, A, Swarup, V. Use of a pocket compression device for the prevention and treatment of pocket hematoma after pacemaker and defibrillator implantation (STOP-HEMATOMA-I). J Intervent Cardiac Electrophysiol 2017;49:197204.
37.Douketis, JD. Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach. Blood 2011;117:50445049.
38.Pindyck, T, Gupta, K, Strymish, J, et al. Validation of an electronic tool for flagging surgical site infections based on clinical practice patterns for triaging surveillance: operational successes and barriers. Am J Infect Control 2018;46:186190.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×
Type Description Title
WORD
Supplementary materials

Asundi et al. supplementary material
Asundi et al. supplementary material 1

 Word (53 KB)
53 KB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed